Alodia Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-12-2024
- Paid Up Capital ₹ 0.12 M
as on 05-12-2024
- Company Age 15 Year, 21 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 Cr
as on 05-12-2024
- Revenue 79.60%
(FY 2022)
- Profit 64.46%
(FY 2022)
- Ebitda 77.73%
(FY 2022)
- Net Worth 70.88%
(FY 2022)
- Total Assets 130.98%
(FY 2022)
About Alodia Life Sciences
The Corporate was formerly known as Athens Life Sciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹3.00 Cr.
Amit Gupta and Yugam Gupta serve as directors at the Company.
- CIN/LLPIN
U33119PB2009PTC033410
- Company No.
033410
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Jalandhar, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alodia Life Sciences Private Limited offer?
Alodia Life Sciences Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Ayurvedic,Herbal Products & Medicine, Ayurvedic Pain Relief Oil, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Alodia Life Sciences?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Amit Gupta | Managing Director | 02-Dec-2009 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yugam Gupta | Director | 26-Feb-2020 | Current |
Financial Performance of Alodia Life Sciences.
Alodia Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 79.6% increase. The company also saw a substantial improvement in profitability, with a 64.46% increase in profit. The company's net worth Soared by an impressive increase of 70.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Alodia Life Sciences?
In 2022, Alodia Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 Mar 2024 | ₹3.00 Cr | Open |
How Many Employees Work at Alodia Life Sciences?
Unlock and access historical data on people associated with Alodia Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alodia Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alodia Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.